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Melioidosis is a bacterial disease that affects humans and many species of 
animals. While some infections are subclinical, others result in localized acute or 
chronic disease, or fatal septicemia. Because it can affect almost any organ, 
melioidosis can mimic many other diseases; it is sometimes called “the great 
imitator.” Infections can also remain asymptomatic for months or years, and emerge 
to cause disease at a later time. A misdiagnosis may be fatal; the causative organism, 
Burkholderia pseudomallei, is susceptible to a limited number of antibiotics.  
In endemic areas, melioidosis is an important cause of illness and death in humans 
and animals. Outside these regions, it can be a concern in travelers, immigrants and 
imported animals. In 1975, a panda is thought to have introduced melioidosis to the 
Paris Zoo, where it caused a severe outbreak. The epidemic spread to other zoos in Paris 
and Mulhouse, and to equestrian clubs throughout France. It decimated some zoo 
populations and caused at least two human deaths. More recently, melioidosis was 
reported in three pet iguanas in the U.S. and the Czech Republic, all of which had 
resided in a non-endemic region for more than a year. The importance of considering 
melioidosis among the diagnostic possibilities is highlighted by such reports, even 
outside areas of known endemicity. An additional concern about B. pseudomallei is that 
has been identified as a potential biological weapon.  
Etiology 
Melioidosis results from infection by Burkholderia pseudomallei, a Gram 
negative bacillus in the family Burkholderiaceae. This organism was formerly known 
as Pseudomonas pseudomallei. The genus Burkholderia contains numerous soil 
organisms, some of which are closely related to B. pseudomallei. It includes B. 
oklahomensis sp. nov., which has been cultured from the soil in North America, and 
caused two human cases originally identified as melioidosis in the U.S. B. 
pseudomallei is also a close relative of B. mallei, the agent of glanders.  
Species Affected 
Many terrestrial and aquatic mammals, as well as marsupials, birds, reptiles and 
fish, can be affected by melioidosis. Goats, sheep and pigs are the most commonly 
infected species in Australia; sheep and goats seem to be particularly susceptible to 
clinical signs. Cases of melioidosis have also been reported in other species including 
dogs, cats, cattle, buffalo, camels, alpacas, horses, mules, bison (Bison bison), zebra 
(Equus burchelli), deer, kangaroos, wallabies, koalas, hog badger (Arctonyx collaris), 
large felids (e.g., cheetah, Acinonyx jubatus, and flat-headed cat, Prionailurus 
planiceps), various nonhuman primates, captive marine mammals, crocodiles, snakes, 
iguanas and tropical fish. This disease has been documented in some species of birds 
including psittacine birds, penguins, ratites and chickens. Some reports suggest that, 
among birds, species not native to endemic regions may be more likely to develop 
melioidosis. Rodents and rabbits can be infected experimentally.  
Zoonotic potential 
Humans are susceptible to B. pseudomallei. This organism is usually acquired 
from environmental sources, but a few zoonotic cases have been described. 
Geographic Distribution 
The exact distribution of B. pseudomallei is uncertain, due to factors such as 
limited laboratory support and/or low clinical suspicion in some areas. Melioidosis is 
mainly reported in parts of Asia (e.g., Southeast Asia, South Asia, China, Singapore, 
Taiwan) and northern Australia. However, indigenous cases in animals or humans, or 
organisms in the environment, have been documented in many other regions 
including the Middle East, South and Central America, Africa and various islands, 
such as the Philippines, Puerto Rico, the Caribbean, New Caledonia, Madagascar and 
Mauritius. Rare cases of melioidosis have been reported from the U.S. and Mexico, in 
people who had not traveled outside this region. To date, environmental sampling has 
not detected B. pseudomallei in North America, and it is possible that these 
individuals were exposed to an unknown, imported source of the organism. Cases in  
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three iguanas in the U.S. and the Czech Republic were 
attributed to chronic infections in animals most likely 
imported from Latin America. Soil sampling in France 
detected B. pseudomallei in several locations after an 
outbreak in the 1970s, but whether it still exists there seems 
to be unclear. 
Transmission 
Animals and humans usually acquire melioidosis from 
organisms in the environment. B. pseudomallei is a 
saprophyte that occurs in soil and water in endemic areas. 
Its environmental niches are still incompletely understood. 
Although this organism is particularly common in moist 
soils, it can also survive for prolonged periods in 
intermittently irrigated soils. It is reported to be common in 
garden soil in some areas. There are occasional reports of 
its isolation from an arid location after flooding, where 
there was no evidence for its presence before that event. 
B. pseudomallei can enter the body by ingestion, via 
inhalation, or through wounds and abrasions. Both animals 
and humans can become chronically infected, with or 
without clinical signs. Infected animals can shed this 
organism in various sources such as wound exudates, nasal 
secretions, milk, feces and urine. Transplacental 
transmission has been documented in several species (goats, 
a pig and a spider monkey). Nosocomial transmission was 
reported in four cats at a veterinary hospital, possibly via 
contamination of a multidose injectable solution. Insects are 
not thought to play any significant role in transmission, 
although B. pseudomallei could be transmitted by 
mosquitoes (Aedes aegypti) and rat fleas (Xenopsylla 
cheopsis) in laboratory experiments.  
There have been a few reports of zoonotic 
transmission, often after skin lesions were exposed to 
infected animals, tissues (including meat) or milk. 
However, most people become infected directly from the 
environment. This occurs through skin wounds in many 
cases, but humans can also acquire B. pseudomallei via 
ingestion (from sources such as contaminated, 
unchlorinated water supplies) or inhalation. Inhalation may 
be particularly important during periods of heavy rainfall 
and strong winds, or during exposure to soil organisms 
from artificial turbulence (e.g., winds generated by 
helicopter blades). Person-to-person transmission has rarely 
been described, and generally occurred to family members 
who had been in close contact through activities such as 
nursing the patient. Possible sexual transmission was 
suggested in rare cases. Some infants seem to have been 
infected from human milk, and transmission may also occur 
in utero, although vertical transmission has rarely been 
proven in people. 
B. pseudomallei can survive for months or years in 
contaminated soil and water. In one report, this organism 
remained viable in triple distilled water at 25°C for 16 
years. Other groups have reported that, under laboratory 
conditions, it can survive in room temperature water for as 
long as 8 weeks, in muddy water for up to 7 months, in soil 
for up to 30 months, and in soil with a water content of less 
than 10% for up to 70 days. B pseudomallei is acid tolerant, 
and has been recovered from water sources ranging in pH 
from 2 to 9 (with good survival in the laboratory at pH ≥ 4). 
It was also reported to remain viable for up to a month in 
water containing salt concentrations as high as 0.4%, with 
little loss in cultivable cell numbers, and to persist for at 
least 4 weeks in a 4% salt solution, although the number of 
viable organisms decreased significantly at this 
concentration. How long B pseudomallei can persist at low 
temperatures is unclear. In two experiments, some strains 
survived for as long as 42 days at 0-2°C.  
B. pseudomallei is capable of existing in a viable but 
non-cultivable state in the environment. While these 
organisms cannot be cultured, they can still cause disease. 
This phenomenon occurs in acid pH, as well as under other 
conditions. The morphology of the viable but non-
cultivable organisms can change. In acid pH, for instance, 
they can appear as Gram-positive, coccoid organisms, 
which revert to conventional Gram-negative-bacilli in 
neutral pH. B. pseudomallei can also enter the cells of some 
protozoa or the mycorrhizal fungus Gigaspora decipiens, a 
characteristic that might help it survive environmental 
stresses.  
Disinfection 
B. pseudomallei is stated to be susceptible to numerous 
disinfectants including 1% sodium hypochlorite, 70% 
ethanol, glutaraldehyde and formaldehyde. However, 
unpublished experiments suggest that it can remain viable 
for some time in 0.3% chlorhexidine, and one outbreak was 
associated with a contaminated container of commercial 
hand-washing detergent. Recent experiments documented 
its susceptibility to a commercial peracetic acid disinfectant 
and Virkon®. Disinfectants may not completely eliminate 
this organism from drinking water, particularly when it is 
protected within protozoa or found in biofilms. Chlorination 
reduces the number of B. pseudomallei in water, but small 
numbers of bacteria have been isolated from water 
containing up to 1000 ppm free chlorine. Strains can differ 
in their sensitivity to this agent. 
B. pseudomallei is also reported to be susceptible to 
inactivation by sunlight. It can be killed by moist heat of 
121°C (249°F) for at least 15 min or dry heat of 160-
170°C (320-338°F) for at least one hour. 
Infections in Animals 
Incubation Period 
The incubation period ranges from days to months or 
years. 
Clinical Signs 
Subclinical infections are common in animals, and 
asymptomatic abscesses may be found at slaughter. 
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Symptomatic melioidosis may be acute, subacute or 
chronic, and mild or severe. The lungs, spleen, liver and 
associated lymph nodes are often involved in animals, but 
any organ can be affected. The effects vary with the site. 
Acute melioidosis, which is most often seen in young 
animals, often occurs as septicemia. Localized respiratory 
signs, gastrointestinal signs, septic arthritis, osteomyelitis, 
mastitis, orchitis, neurological signs, mycotic aneurysms 
and other syndromes may be also seen. Septicemia or 
extensive involvement of the vital organs can be fatal.  
Forms of melioidosis reported in mammals  
and birds 
Pulmonary melioidosis is common in sheep, with 
clinical signs that can include fever, severe coughing, 
respiratory distress and profuse mucopurulent yellow 
nasal and ocular discharge. Some sheep become arthritic 
and lame. In others, the only signs may be fever and 
generalized weakness. Neurological signs have also been 
reported. Orchitis with testicular nodules can occur in 
rams. In goats, respiratory disease is reported to be less 
severe than in sheep, and coughing may not be a 
prominent sign. Progressive emaciation, lameness or 
hindleg paresis, aortic aneurysms and abortions have also 
been documented in this species. Mastitis appears to be a 
common syndrome in goats. 
Pigs may be relatively resistant to melioidosis when 
husbandry and nutrition are good. Adult pigs tend to 
develop chronic infections with few clinical signs; however, 
enlarged lymph nodes (particularly the submandibular 
nodes) may be palpable. Progressive emaciation, 
neurological signs, incoordination, multiple skin ulcers and 
diarrhea have also been reported. Young pigs can develop 
acute septicemia with fever, anorexia, coughing and nasal 
and ocular discharge. Occasional abortions or stillbirths 
have been seen in sows, and orchitis can occur in boars. In 
endemic regions, asymptomatic splenic abscesses are often 
found in pigs at slaughter. 
Various forms of melioidosis have been reported in 
horses. Generally, the disease lasts approximately a few 
weeks to a few months, with clinical signs that may include 
weakness, emaciation, edema and lymphangitis of the 
limbs, mild colic, diarrhea, and signs of pneumonia 
including coughing and nasal discharge. Skin infections can 
initially resemble fungal eczema, but later become papular. 
Hyperacute septicemia with high fever, limb edema, 
diarrhea and rapid death has also been seen. Acute 
meningoencephalitis has been reported in rare cases.  
Melioidosis has rarely been described in cattle. Most 
cases in adult cattle have been chronic. Fever, dyspnea, 
continuous profuse salivation and neurologic signs were 
reported in one animal. In two other cases, abscessation or 
acute, localized arthritis occurred after wound contamination. 
Acute melioidosis was reported in a calf.  
Camels may develop chronic respiratory disease with a 
hacking cough, purulent nasal discharge and dyspnea. Other 
animals had hindleg ataxia and a wasting disease with 
severe emaciation. Acute septicemia has been seen in both 
camels and alpacas.  
Acute, subacute or chronic melioidosis can occur in 
dogs. Acute cases in this species are often characterized by 
septicemia. Signs may include fever, severe diarrhea and 
fulminant pneumonia. Subacute disease can begin as a skin 
lesion with lymphangitis and lymphadenitis; untreated cases 
may progress to septicemia over a week to several months. 
Respiratory disease can also be the initial syndrome. In 
addition, chronic disease can occur in any organ; it may be 
accompanied by anorexia, myalgia, edema of the limbs and 
skin abscesses.  
Abscesses have also been reported in various organs in 
cats. In two published cases, the clinical signs were not 
strongly suggestive of an infectious disease. One cat 
presented with jaundice and anemia, and died soon after it 
was seen. Fatal neurological disease was reported in the 
second cat, possibly after dissemination from an infected 
foot wound.  
Nonspecific signs of illness, fever, generalized 
lymphadenopathy and respiratory signs were common in 
affected zoo mammals and marsupials in Thailand. Most 
cases in captive marine mammals have been characterized 
by acute septicemia with fever, inappetence, anorexia and 
listlessness followed by death. Unlike other species, 
respiratory distress was not reported. Enteric disease with 
diarrhea and liver abscesses has been seen in some 
dolphins. Three cases in iguanas were characterized by 
masses in internal organs and/or external abscesses. Some 
animals had recurrent or repeated abscess formation. 
Although birds may be relatively resistant to 
melioidosis, fatal cases with lethargy, anorexia and diarrhea 
have been reported in various avian species in Australia. 
Experimentally infected chickens remained asymptomatic; 
however, facial abscesses were reported in a naturally 
infected chicken.  
Post Mortem Lesions      Click to view images 
At necropsy, the major findings are multiple abscesses 
containing thick, caseous, greenish-yellow or off-white 
material. These abscesses are generally not calcified. The 
regional lymph nodes, lungs, spleen, liver and subcutaneous 
tissues are most often involved, but abscesses can occur in 
most organs. Splenic abscesses are reported to be common 
in asymptomatic pigs at slaughter. In animals with 
respiratory disease, exudative bronchopneumonia, 
consolidation and/or abscesses may be found in the lungs. 
Suppurative lesions including nodules and ulcers may also 
be detected on the nasal mucosa and septum, as well as on 
the turbinate bones. These nodules may coalesce to form 
irregular plaques. Meningoencephalitis, severe enteritis, 
suppurative polyarthritis, mycotic aneurisms, mastitis and 
other syndromes have also been documented in animals. 
Diffuse pinpoint nodules in the liver and spleen are reported 
to be common lesions in birds. 
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Diagnostic Tests 
Culturing B. pseudomallei is currently considered to be 
the gold standard test for melioidosis in both animals and 
people. This organism may be found in various sites 
including abscesses and wound exudates, milk, feces, throat 
swabs, blood, urine, and tissues collected at necropsy. It 
will grow on most media including blood agar. Selective 
media such as Ashdown's medium are often used in 
endemic regions. Ashdown’s medium selects for 
gentamicin resistance, a characteristic of most B. 
pseudomallei; however, gentamicin-susceptible strains were 
recently reported to be common in some areas. Colonies of 
B. pseudomallei can be identified by biochemistry 
combined with microscopic and culture appearance. On 
microscopic examination, the organisms are classically 
described as motile, short Gram negative bacilli, with 
bipolar or irregular staining. However, their form can differ 
from this description, for instance in older cultures or 
clinical samples. PCR and antigen detection tests (e.g., latex 
agglutination, immunofluorescence) are also used for 
identification. There have been multiple reports of the 
misidentification of B. pseudomallei by automated 
identification systems, although some sources indicate that 
these systems can identify most isolates. It is also possible 
to mistake this organism for Pseudomonas or a contaminant 
during manual culture and identification. Misidentification 
is a particular concern in non-endemic areas, where the 
isolation of B. pseudomallei is unexpected. B. pseudomallei 
is a biosafety level 3 organism, and not all laboratories are 
equipped to safely culture and identify this organism. 
Other tests that can be used to identify B. pseudomallei 
in clinical samples include antigen detection assays such as 
direct immunofluorescence, latex agglutination or ELISAs, 
and PCR tests to detect nucleic acids. The specific tests 
available can differ between regions, and PCR does not 
appear to be widely used at present. Genetic techniques that 
may be used for epidemiological purposes include PCR–
restriction fragment length polymorphism, pulse-field gel 
electrophoresis, 16S rRNA sequencing, variable number 
tandem repeat polymorphism and multilocus sequence 
typing (MLST). These tests may be available mainly in 
research laboratories. 
Serology is sometimes used to diagnose melioidosis in 
animals, but it is not considered to be definitive. Animals in 
endemic areas often have pre-existing titers to this 
organism, and there may be cross-reactions with closely 
related species such as B. mallei or B, cepecia. False 
positives have also been reported from other Gram negative 
bacteria including Legionella spp. Some of the available 
serological tests include indirect hemagglutination, 
immunofluorescence and complement fixation. 
Environmental samples are sometimes taken from soil 
and/ or water during outbreaks or case investigations. 
Recommended methods and sampling protocols for 
surveillance have been published. 
Treatment 
B. pseudomallei is susceptible to some antibiotics; 
however, this organism is intrinsically resistant to many 
drugs, including some that are commonly used to treat 
bacterial infections. Because relapses can occur when 
treatment is stopped, animals given antibiotics may need to 
be monitored afterward. Treatment regimens similar to 
those currently used in humans, with intravenous therapy 
followed by an eradication stage, may be effective in 
animals; however, there are no published reports evaluating 
their use.  
Because treatment can be expensive and protracted, 
and it may not eliminate the organism, some animals are 
euthanized instead. Treatment of infected animals may not 
be allowed in some areas. 
Control 
Disease reporting 
Veterinarians who suspect melioidosis should follow 
their national and/or local guidelines for disease reporting. 
In the U.S., this disease is reportable in animals in some 
states. State or federal authorities should be consulted for 
specific regulations and information.   
Prevention 
Melioidosis is usually acquired from the environment, 
particularly after contact with soil or water. To minimize 
contact with dirt, animals can be raised on wooden slats, 
concrete or paved floors. Providing safe drinking water 
(e.g., by filtration and chlorination) is also important in 
endemic areas. Carnivores and omnivores should not be 
allowed to eat contaminated carcasses. Licensed vaccines 
are not available. 
Euthanasia of infected animals is often recommended 
even in endemic areas, because melioidosis is difficult to 
treat and can be zoonotic. After culling infected animals, 
the premises should be disinfected. Disinfecting some 
environments may be difficult. The soil in one exhibit at a 
Thai zoo was decontaminated by mixing in quicklime 
(calcium oxide) and left for approximately one year, after 
which time repeat cultures found no evidence of B. 
pseudomallei. If infected animals are not euthanized, 
precautions should be taken to protect people and other 
animals. Strict hygiene is necessary to prevent transmission 
from infected horses in stables. The feces should be 
removed several times a day, and the premises, and the 
hooves and lower legs of the animals should be disinfected 
regularly. Food and water should be provided as aseptically 
as possible. Standing water should be allowed only in 
limited quantities or disinfected immediately.  
Morbidity and Mortality 
Susceptibility to melioidosis may differ between 
species and individual animals. Immunosuppression may 
predispose cats and dogs to this disease. Pigs generally 
seem to be more resistant to clinical signs than sheep and 
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goats, and infections in cattle are very rarely reported. One 
report indicated that, among zoo animals, orangutans 
(Pongo pygmaeus) appeared to be unusually susceptible, 
with cases usually developing into septicemia and ending in 
death within a week. Although melioidosis does not appear 
to be a problem in marine mammals in the wild, an 
outbreak occurred in marine mammals at a Hong Kong 
oceanarium after heavy summer rains washed soil into the 
animals’ water.  
The mortality rate varies with the site of the lesions, 
but can be high in sheep. Extensive abscesses and 
involvement of the vital organs can be fatal. Septicemia has 
a high case fatality rate, but it seems to be less common in 
animals than humans. Most cases of septicemia are seen in 
young animals. 
Infections in Humans 
Incubation Period 
The incubation period in humans varies from less than 
a day (after very high exposure) to several months or years. 
In one study, most acute cases became apparent within 21 
days after exposure, with a mean of 9 days. A few cases 
have remained subclinical for up to 29 years, and one 
infection apparently became symptomatic after 62 years. 
Clinical Signs 
B. pseudomallei can cause a wide spectrum of clinical 
signs in people. While many infections seem to be 
inapparent, some result in acute pulmonary disease, 
septicemia, or localized acute or chronic suppurative 
infections. The frequency of the various syndromes can 
differ between regions. For example, parotid abscesses are 
common among children in Thailand, but rare in Australia. 
One syndrome can develop into another if the organisms 
spread to other sites.  
Acute localized infections sometimes occur at the site 
of inoculation. In Australia, localized skin disease was 
reported to be a common form of melioidosis in children. 
Lesions in the skin typically appear as gray or white, firm 
nodules and ulcers, which are often but not always single. 
The nodules may caseate, and are often surrounded by 
inflammation. They may be accompanied by regional 
lymphadenopathy and lymphangitis. Other forms of acute 
localized disease include suppurative parotitis/ parotid 
abscesses, destructive corneal ulcers seen after corneal 
trauma, and cellulitis or infections that resemble necrotizing 
fasciitis. Genitourinary infections often manifest as 
prostatic abscesses. Localized infections can disseminate, 
but systemic infections are not always preceded by 
localized signs. Skin and subcutaneous infections can also 
result from the hematogenous spread of organisms from 
other sites. 
Pulmonary disease is a common syndrome in people. It 
can occur as either the primary syndrome or a component of 
septicemia, and may develop either suddenly or gradually 
after a nonspecific prodromal illness. Pulmonary 
melioidosis ranges in severity from mild acute or subacute 
pneumonia to respiratory distress with overwhelming septic 
shock. Common symptoms include fever, coughing, 
pleuritic chest pain and, in some cases, hemoptysis. 
However, patients with pneumonia as a component of 
septicemia often have little coughing or pleuritic pain, 
although they are febrile and severely ill. Chronic 
pulmonary melioidosis can wax and wane and resembles 
tuberculosis, with weight loss, fevers, night sweats, and a 
productive cough, sometimes with blood-tinged sputum. 
Ulcerative lesions and nodules are sometimes found in the 
nose, and the septum may perforate. Complications may 
include pneumothorax, empyema and pericarditis. 
Untreated cases can progress to septicemia. 
Septicemia is the most serious form of melioidosis. It is 
most common in people with pre-existing diseases such as 
diabetes, cancer and kidney failure. The onset is usually 
acute, with fever, rigors and other typical signs of sepsis. 
However, it may develop more gradually in some patients, 
with a fluctuating fever often associated with severe weight 
loss. Common symptoms of septicemic melioidosis include 
fever, severe headache, disorientation, pharyngitis, upper 
abdominal pain, diarrhea, jaundice and notable muscle 
tenderness. Pulmonary signs including dyspnea are 
common, and arthritis or meningitis may be seen. Some 
patients have a disseminated pustular rash with regional 
lymphadenopathy, cellulitis or lymphangitis. Septic shock 
is common and life-threatening. 
In chronic cases, abscesses and suppurative lesions can 
occur in a variety of organs. Although the liver, spleen, 
skeletal muscle and prostate gland are often affected, 
lesions may be found in a variety of other organs including 
the skin, lung, kidney, myocardium, bone, joints, lymph 
nodes and testes. Mycotic aneurysms are also seen. 
Uncommonly, melioidosis can result in brain abscesses, 
encephalomyelitis (with various syndromes including 
flaccid paralysis) or meningitis. There may be severe 
residual defects in cases of encephalitis.  
Diagnostic Tests 
Isolation of B. pseudomallei in culture is considered to 
be the gold standard test for melioidosis in people, as it is in 
animals, and the techniques are the same. In human clinical 
cases, B. pseudomallei can be recovered from sources such 
as blood, sputum, throat or rectal swabs, urine, skin lesions 
or ulcer swabs, tissues and wound exudates. Sampling 
multiple sites, rather than limiting samples to the apparent 
focus of the infection, is more likely to detect the organism. 
B. pseudomallei can sometimes be found in samples such as 
urine even if there are no signs associated with the urinary 
tract. Culture is not successful in all cases of melioidosis.  
B. pseudomallei antigens may be identified directly in 
tissues, wound exudates or body fluids by assays such as 
direct immunofluorescence or latex agglutination, 
particularly if the number of bacteria is high. Lateral flow 
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immunoassays have also been developed. PCR is reported 
to be no more sensitive than culture for detecting 
melioidosis in humans, and does not seem to be widely 
used at present. Matrix-assisted laser desorption ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) 
methods are being investigated. As in animals, specialized 
genetic techniques can be used in epidemiological studies. 
Serological tests may be helpful in some 
circumstances, particularly when paired sera are available. 
In some cases, a high single titer in the presence of clinical 
signs may be suggestive. However, most of the population 
is seropositive in some (but not all) endemic areas, limiting 
the value of these assays. A number of serological tests 
have been described in humans, including agglutination, 
indirect hemagglutination, immunofluorescence, ELISAs, 
and immunochromatographic tests (ICT). Test availability 
differs between regions, but indirect hemagglutination is a 
commonly used test. People with symptomatic melioidosis 
are occasionally seronegative, and cross-reactivity with 
other organisms is possible.  
Treatment 
Although a few cases with only localized skin lesions 
were reported to heal spontaneously, melioidosis is treated 
even when it is localized or mild, due to the risk that the 
organism may persist and/or disseminate.  
B. pseudomallei is not susceptible to some drugs that 
are often used empirically to treat infections. Combinations 
of drugs were generally used for treatment in the past, but 
some newer single antibiotics are equally effective. At 
present, the recommended protocol is a two-stage therapy. 
Initially, patients receive intravenous antibiotics for a 
minimum of 10-14 days (longer in some conditions). This is 
followed by prolonged antibiotic treatment, usually with 
oral drugs, for several months or longer. The purpose of the 
second stage is to eliminate the organisms from the body. 
Prolonged oral treatment alone was reported to be effective 
in some milder conditions in healthy people. Some patients 
also require adjunct treatments, such as supportive therapy 
for septic shock. Pulmonary resection or drainage of 
abscesses is occasionally necessary.  
At one time, up to 30% of patients relapsed after being 
treated for melioidosis. However relapses are much less 
common with newer treatment regimens, and tend to occur 
mainly in cases where the course of antibiotics is not 
completed.  
Control 
B. pseudomallei is widely distributed in soil and 
standing water in endemic regions. Skin wounds (including 
abrasions or burns) should be protected from potential 
contamination, and promptly and thoroughly cleansed if 
they become exposed. Gloves and rubber boots are 
recommended for anyone doing agricultural work. Because 
B. pseudomallei can be found in milk from infected 
ruminants, only pasteurized dairy products should be 
consumed. Chlorination of the water supply decreases the 
risk of infection from this source, and carcasses with signs 
of melioidosis are condemned and not used for human food. 
People who process meat should wear gloves and disinfect 
their knives regularly. Veterinarians should also take 
precautions to avoid exposure, including the use of gloves 
and protective clothing, when working with infected 
animals or collecting diagnostic samples. People with 
diabetes or other predisposing conditions should be 
especially vigilant in avoiding exposure, including potential 
inhalation during severe weather events. Screening for 
melioidosis has been recommended for patients who will be 
starting immunosuppressive therapy in an endemic area. 
Laboratory workers may be exposed in clinical samples 
from patients, even where melioidosis is not endemic. 
Practices such as sniffing opened culture plates should be 
discouraged. Postexposure prophylaxis may sometimes be 
given after laboratory exposure, but its effectiveness is 
currently uncertain. In hospitals, ordinary precautions to 
prevent transmission in blood and body fluids should be 
taken. No vaccine is currently available for humans. 
Morbidity and Mortality 
Melioidosis can occur as sporadic cases or outbreaks in 
endemic regions. The number of cases typically increases 
after heavy rainfall or flooding. While this disease is most 
common in tropical and subtropical areas, it has been 
reported in arid regions after floods. Some outbreaks have 
been linked to contaminated drinking water supplies, and 
occasionally to unusual sources, such as a container of 
contaminated hand washing detergent. Occasional cases 
occur outside endemic areas in immigrants and travelers. 
Most human illnesses seem to appear soon after exposure; 
however, B. pseudomallei can persist asymptomatically in 
the body and cause disease at a later time, typically when 
another condition causes the person to become debilitated 
or immunosuppressed. One study in Australia suggested 
than <4% of recognized cases potentially result from the 
reactivation of latent lesions.  
The incidence of melioidosis is reported to peak 
between the ages of 40 and 60 among adults in Thailand. 
This disease is particularly common in people with 
diabetes. Other chronic conditions including thalassemia, 
kidney disease, chronic lung disease, cancer and 
alcoholism, as well as the use of immunosuppressive drugs 
(e.g., steroids), also increase the risk of illness. However, 
some cases occur in previously healthy people. Children 
account for 5-15% of melioidosis cases in Australia, and do 
not have any risk factors in most cases. Seroprevalence 
rates vary widely in endemic regions: while > 50% of the 
population may be seropositive in parts of Thailand, one 
study reported that antibodies to B. pseudomallei occurred 
in <10% of people at high risk of exposure in Australia. It is 
currently unclear how many seropositive people without 
clinical signs might be carrying this organism. Colonization 
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without disease is currently considered unlikely, although 
there are reports suggesting that it might occur. 
The severity of melioidosis is influenced by factors 
such as the host’s immunity, the form of the disease, and 
the dose and possibly the strain of the organism. For 
example, acute suppurative parotiditis or localized skin 
disease in children usually has a good prognosis. 
Conversely, septic shock is rapidly fatal without treatment, 
and has a high risk of death even with good care. Case 
fatality rates for melioidosis have decreased in recent years 
in some areas, most likely due to improved recognition and 
treatment. Recent estimates of the overall mortality rate for 
all patients range from approximately 10% in Australia to 
40% in Thailand, and can be higher in other areas where 
only limited medical care is available. Australia reports that 
deaths are currently uncommon in patients without known 
risk factors for melioidosis, provided there is prompt 
recognition of the condition, treatment with appropriate 
antibiotics, and state-of-the-art management of sepsis. In 
one large prospective study from Australia, the case fatality 
rate ranged from 4% in patients without septic shock to 
50% in patients with septic shock. Cases in infants can also 
be severe. One review reported a case fatality rate of 73% 
in published cases of neonatal melioidosis.. 
Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/melioidosis/index.html  
eMedicine. Glanders and Melioidosis  
http://emedicine.medscape.com/article/830235-
overview  




The Merck Manual 
http://www.merckmanuals.com/professional  
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.html   
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